한글목차

세계의 지혈제 시장은 2024년에 38억 2,000만 달러로 평가되었으며, 2030년까지 CAGR 7.48%로 성장하여 58억 9,000만 달러에 달할 것으로 예측됩니다.

지혈제는 수술 중, 외상 또는 각종 질환에서 출혈을 멈추기 위해 사용되는 특수 의료기기 또는 약물로, 응고를 촉진하거나 기계적 장벽을 제공하거나 응고를 방지하는 역할을 합니다. 세계 지혈제 시장의 성장은 주로 전 세계 외과적 개입의 증가, 외과적 치료가 필요한 다양한 만성질환에 취약한 고령화 인구의 증가, 외상 사례의 증가에 의해 주도되고 있습니다.

주요 시장 촉진요인

세계 지혈제 시장은 고령화 인구의 증가와 지혈 기술의 지속적인 발전이 맞물려 큰 영향을 받고 있습니다. 전 세계적으로 노인 인구의 비율이 증가함에 따라 외과적 개입이 필요한 환자층이 크게 확대되고 있습니다.

주요 시장 과제

엄격하고 복잡한 규제 승인 절차는 세계 지혈제 시장 성장에 큰 장벽이 되고 있습니다. 이러한 까다로운 요구 사항으로 인해 개발 기간이 길어지고 제조업체의 비용이 크게 증가했습니다.

주요 시장 동향

최소침습 수술법의 보급 확대는 특수 출혈 제어 솔루션에 대한 수요를 창출하고, 세계 지혈제 시장에 큰 영향을 미치고 있습니다. 이러한 기술은 환자의 회복 촉진과 입원 기간 단축을 기대할 수 있어 다양한 수술 분야에서 점점 더 많은 적용이 이루어지고 있습니다.

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 지혈제 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 종류별(트롬빈계 지혈제, 산화 재생 셀룰로오스계 지혈제, 복합형 지혈제, 젤라틴계 지혈제, 콜라겐계 지혈제, 기타 지혈제)
  • 제제별(매트릭스·겔 지혈제, 시트·패드 지혈제, 스펀지 지혈제, 분말 지혈제)
  • 용도별(정형외과 수술, 일반외과 수술, 신경외과 수술, 심혈관외과 수술, 재건외과 수술, 부인과 수술, 기타 외과적 용도)
  • 지역별
  • 기업별(2024)
• 시장 맵

제6장 북미의 지혈제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 지혈제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 지혈제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 중동 및 아프리카의 지혈제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 사우디아라비아
  • 아랍에미리트
  • 남아프리카공화국

제10장 남미의 지혈제 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 콜롬비아
  • 아르헨티나

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 세계의 지혈제 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제15장 경쟁 구도

• Johnson & Johnson
• Baxter International Inc.
• Pfizer Inc
• B Braun Medical Inc
• Becton, Dickinson, and Company
• Teleflex Incorporated
• Medtronic Plc
• Hemostasis, LLC
• Stryker Corporation
• Integra LifeSciences Corporation

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

영문목차

The Global Hemostats Market, valued at USD 3.82 Billion in 2024, is projected to experience a CAGR of 7.48% to reach USD 5.89 Billion by 2030. Hemostats are specialized medical devices or agents employed to arrest bleeding during surgical procedures, traumatic injuries, or in various medical conditions by promoting coagulation or providing a mechanical barrier. The global hemostats market growth is principally driven by an escalating volume of surgical interventions worldwide, a progressively aging global population prone to various chronic diseases requiring surgical treatment, and the rising incidence of trauma cases.

Key Market Drivers

The Global Hemostats Market is significantly influenced by the confluence of a growing geriatric population and continuous advancements in hemostatic technologies. The increasing proportion of older adults globally represents a substantial and expanding patient demographic requiring surgical intervention. This demographic often presents with multiple comorbidities, necessitating more frequent and complex procedures where effective bleeding control is paramount. For instance, according to a study highlighted by ResearchGate in August 2025, older individuals typically require surgical procedures four times more often than the younger population, directly increasing the demand for hemostatic agents during these interventions.

Key Market Challenges

The stringent and complex regulatory approval processes represent a significant impediment to the growth of the Global Hemostats Market. These rigorous requirements necessitate protracted development timelines and substantially increased costs for manufacturers. Such an environment diverts significant financial and human capital towards compliance rather than innovation, thereby slowing the introduction of novel hemostatic solutions to address unmet clinical needs.

Key Market Trends

The expanding adoption of minimally invasive surgical approaches significantly influences the global hemostats market by creating demand for specialized bleeding control solutions. These techniques, favored for enhanced patient recovery and reduced hospital stays, are increasingly applied across diverse surgical disciplines. According to the National Institutes of Health, over 1 million hip and knee arthroplasty procedures were performed annually in the U. S. in 2024, a large volume where minimally invasive techniques are increasingly utilized. This procedural shift necessitates hemostatic agents that are effective and precisely applicable within constricted surgical fields.

Key Market Players

• Johnson & Johnson
• Baxter International Inc.
• Pfizer Inc
• B Braun Medical Inc
• Becton, Dickinson, and Company
• Teleflex Incorporated
• Medtronic Plc
• Hemostasis, LLC
• Stryker Corporation
• Integra LifeSciences Corporation

Report Scope:

In this report, the Global Hemostats Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hemostats Market, By Type:

• Thrombin-based Hemostats
• Oxidized Regenerated Cellulose-based Hemostats
• Combination Hemostats
• Gelatin-based Hemostats
• Collagen-based Hemostats
• Other Hemostats

Hemostats Market, By Formulation:

• Matrix & Gel Hemostats
• Sheet & Pad Hemostats
• Sponge Hemostats
• Powder Hemostats

Hemostats Market, By Application:

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Other Surgical Applications

Hemostats Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hemostats Market.

Available Customizations:

Global Hemostats Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hemostats Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Thrombin-based Hemostats, Oxidized Regenerated Cellulose-based Hemostats, Combination Hemostats, Gelatin-based Hemostats, Collagen-based Hemostats, Other Hemostats)
  • 5.2.2. By Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats)
  • 5.2.3. By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Surgical Applications)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Hemostats Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Formulation
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hemostats Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Formulation
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Hemostats Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Formulation
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Hemostats Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Formulation
      • 6.3.3.2.3. By Application

7. Europe Hemostats Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Formulation
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hemostats Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Formulation
      • 7.3.1.2.3. By Application
  • 7.3.2. France Hemostats Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Formulation
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Hemostats Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Formulation
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Hemostats Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Formulation
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Hemostats Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Formulation
      • 7.3.5.2.3. By Application

8. Asia Pacific Hemostats Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Formulation
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hemostats Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Formulation
      • 8.3.1.2.3. By Application
  • 8.3.2. India Hemostats Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Formulation
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Hemostats Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Formulation
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Hemostats Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Formulation
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Hemostats Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Formulation
      • 8.3.5.2.3. By Application

9. Middle East & Africa Hemostats Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Formulation
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hemostats Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Formulation
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Hemostats Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Formulation
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Hemostats Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Formulation
      • 9.3.3.2.3. By Application

10. South America Hemostats Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Formulation
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hemostats Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Formulation
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Hemostats Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Formulation
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Hemostats Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Formulation
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hemostats Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Johnson & Johnson
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Baxter International Inc.
• 15.3. Pfizer Inc
• 15.4. B Braun Medical Inc
• 15.5. Becton, Dickinson, and Company
• 15.6. Teleflex Incorporated
• 15.7. Medtronic Plc
• 15.8. Hemostasis, LLC
• 15.9. Stryker Corporation
• 15.10. Integra LifeSciences Corporation

16. Strategic Recommendations

17. About Us & Disclaimer